2021-01-04,"Acceleron to Participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021"
2020-12-30,Acceleron Pharma Looks Poised to Continue Bull Run in 2021
2020-12-22,Is XLRN A Good Stock To Buy According To Hedge Funds?
2020-12-22,Top Healthcare Stocks for January 2021
2020-12-21,"The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals"
2020-12-21,5 Biotech Stocks That More Than Doubled This Year
2020-12-18,5 Healthcare Stocks That Fared Well in 2020 Amid the Pandemic
2020-12-15,Acceleron's (XLRN) PAH Candidate Gets Orphan Designation in EU
2020-12-15,"The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding"
2020-12-14,Acceleron Receives Orphan Designation from the European Commission (EC) for Sotatercept in Pulmonary Arterial Hypertension (PAH)
2020-12-11,Is Acceleron Pharma (XLRN) a Smart Long-term Buy?
2020-12-05,Acceleron (XLRN) Up 8.6% Since Last Earnings Report: Can It Continue?
2020-12-02,Acceleron (XLRN) Gets Orphan Drug Tag for ACE-1334 by FDA
2020-12-01,Acceleron Receives FDA Orphan Drug Designation for ACE-1334 for the Treatment of Systemic Sclerosis
2020-11-16,Analysts' Revenue Estimates For Acceleron Pharma Inc. (NASDAQ:XLRN) Are Surging Higher
2020-11-13,Acceleron Presents Preliminary Interim Data from the SPECTRA Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) at the 2020 American Heart Association Scientific Sessions
2020-11-13,"Acceleron Presents New Data from the PULSAR Phase 2 Trial, Preclinical Research on Sotatercept in Pulmonary Arterial Hypertension (PAH) at the 2020 American Heart Association (AHA) Scientific Sessions"
2020-11-09,"Acceleron Announces Clinical Trial Updates, Preclinical Presentation on Sotatercept in Pulmonary Arterial Hypertension at the 2020 American Heart Association (AHA) Scientific Sessions"
2020-11-06,New Strong Sell Stocks for November 6th
2020-11-06,Acceleron Pharma Inc (XLRN) Q3 2020 Earnings Call Transcript
2020-11-05,"Acceleron Pharma (XLRN) Reports Q3 Loss, Lags Revenue Estimates"
2020-11-05,"Acceleron Pharma, Inc. to Host Earnings Call"
2020-11-05,Acceleron Reports Third Quarter 2020 Operating and Financial Results
2020-11-05,Acceleron Announces Third Quarter 2020 REBLOZYL® Net Sales
2020-11-04,Acceleron Announces REBLOZYL® (luspatercept-aamt) Virtual Presentations at the 62nd American Society of Hematology Annual Meeting
2020-10-29,Acceleron Pharma (XLRN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2020-10-28,Is Acceleron Pharma Inc. (NASDAQ:XLRN) Trading At A 40% Discount?
2020-10-26,Were Hedge Funds Right About Embracing Acceleron Pharma Inc (XLRN)?
2020-10-26,"Acceleron to Webcast Third Quarter 2020 Operating and Financial Results on November 5, 2020"
2020-09-30,"The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac"
2020-09-29,"Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia"
2020-09-17,"Acceleron to Host Webcast Outlining the Design of Its Registrational Phase 3 STELLAR Trial of Sotatercept in Pulmonary Arterial Hypertension (PAH) on October 2, 2020"
2020-09-16,Acceleron Appoints Laura J. Hamill to its Board of Directors
2020-09-13,Companies Like Acceleron Pharma (NASDAQ:XLRN) Are In A Position To Invest In Growth
2020-09-05,Why Is Acceleron (XLRN) Down 15.1% Since Last Earnings Report?
2020-08-31,Hedge Funds Have Never Been This Bullish On Acceleron Pharma (XLRN)
2020-08-26,5 Biotech Stocks That Could Be Worth a Look
2020-08-07,Acceleron (XLRN) Reports Narrower-Than-Expected Q2 Loss
2020-08-06,"Acceleron Pharma (XLRN) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Acceleron Reports Second Quarter 2020 Operating and Financial Results
2020-08-06,Acceleron Announces Second Quarter 2020 REBLOZYL® Net Sales
2020-08-03,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Acceleron Pharma Inc. - XLRN"
2020-07-30,Acceleron Pharma (XLRN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2020-07-27,Acceleron Pharma (XLRN) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
2020-07-27,"Acceleron to Webcast Second Quarter 2020 Operating and Financial Results on August 6, 2020"
2020-07-23,Edited Transcript of XLRN.OQ earnings conference call or presentation 27-Feb-20 10:00pm GMT
2020-07-13,Did Hedge Funds Make The Right Call On Acceleron Pharma Inc (XLRN) ?
2020-07-11,"Notable Insider Buys: Acceleron, Continental And Syneos Health"
2020-07-07,Acceleron Announces Closing of Public Offering of Common Stock and Exercise of Underwriters Option to Purchase Additional Shares
2020-07-06,"XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm"
2020-07-06,Acceleron (XLRN) in Focus: Stock Moves 5.3% Higher
2020-07-02,10 Stocks to Invest in the Health Care Revolution
2020-06-30,Acceleron Announces Pricing of Public Offering of Common Stock
2020-06-29,Acceleron Announces Proposed Public Offering of Common Stock
2020-06-29,Bristol Myers & Acceleron Obtain EC Approval for Reblozyl
2020-06-26,European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia
2020-06-24,Acceleron Pharma stock jumps after positive heart-drug study
2020-06-24,Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
2020-06-22,Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020 Virtual Conference
2020-06-11,Edited Transcript of XLRN earnings conference call or presentation 11-May-20 9:00pm GMT
2020-06-10,Acceleron (XLRN) Down 6.2% Since Last Earnings Report: Can It Rebound?
2020-06-04,Acceleron Appoints Christopher Hite to its Board of Directors
2020-06-01,Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)
2020-05-20,Acceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2020 American Society of Clinical Oncology and European Hematology Association Virtual Annual Meetings
2020-05-19,"Acceleron Announces Oral Presentation of PULSAR Phase 2 Trial Results in Virtual American Thoracic Society 2020 Conference Session on June 24, 2020"
2020-05-13,Acceleron Announces Publication in Science Translational Medicine Describing the Underlying Biology Behind Sotatercepts Potential as a Novel Therapy in Pulmonary Arterial Hypertension
2020-05-12,Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript
2020-05-12,"Acceleron (XLRN) Q1 Loss Wider Than Expected, Revenues Miss"
2020-05-11,"Acceleron Pharma (XLRN) Reports Q1 Loss, Lags Revenue Estimates"
2020-05-11,Acceleron Reports First Quarter 2020 Operating and Financial Results
2020-05-05,"Acceleron to Webcast First Quarter 2020 Operating and Financial Results on May 11, 2020"
2020-05-04,Acceleron Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Sotatercept in Pulmonary Arterial Hypertension
2020-05-02,A strategy of buying the fastest-growing businesses in America has paid off for this investor in 2020
2020-04-30,Reblozyl (luspatercept) Receives Positive CHMP Opinion for the Treatment of Adults with Anemia in Beta Thalassemia and Myelodysplastic Syndromes
2020-04-24,7 Beautiful Biotech Stocks to Buy Here
2020-04-21,Keros Therapeutics Shares Climb 70% After First Post-Covid-19 Biotech IPO
2020-04-09,An Intrinsic Calculation For Acceleron Pharma Inc. (NASDAQ:XLRN) Suggests It's 40% Undervalued
2020-04-08,Biotech raises $96M IPO during downturn
2020-04-08,"The Daily Biotech Pulse: Genmark Pre-Announces Q1 Outperformance, Sage to Eliminate 53% of Workforce, Keros IPO"
2020-04-08,Acceleron Receives FDA Breakthrough Therapy Designation for Sotatercept in Pulmonary Arterial Hypertension
2020-04-07,Acceleron Announces Retirement of Director Jean George
2020-04-06,Bristol Myers/Acceleron's Reblozyl Label Expansion Gets FDA Nod
2020-04-06,Acceleron Receives Thumbs Up From Street On FDA Reblozyl Label Expansion
2020-04-03,"U.S. Food and Drug Administration (FDA) Approves Reblozyl® (luspatercept-aamt), the First and Only Erythroid Maturation Agent, to Treat Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS)"
2020-03-29,Do Hedge Funds Love Acceleron Pharma Inc (XLRN)?
2020-03-29,"The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty"
2020-03-26,New England Journal of Medicine Publishes Results from Pivotal Phase 3 BELIEVE Trial of Reblozyl (luspatercept-aamt) in Adult Patients With Beta Thalassemia
2020-03-09,Acceleron Announces Topline Results from the Phase 2 Trial of ACE-083 in Patients with Charcot-Marie-Tooth Disease
2020-03-04,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
2020-02-27,"Acceleron Pharma (XLRN) Reports Q4 Loss, Tops Revenue Estimates"
2020-02-26,Is a Surprise Coming for Acceleron Pharma (XLRN) This Earnings Season?
2020-02-26,Acceleron to Participate in Two Upcoming Healthcare Investor Conferences
2020-02-20,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Acceleron Pharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
2020-02-20,Acceleron Pharma (XLRN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2020-02-19,Blood disorder startup files for $86M IPO
2020-02-18,Is Acceleron Pharma Inc.'s (NASDAQ:XLRN) CEO Pay Justified?
2020-02-18,"Acceleron to Webcast Fourth Quarter and Full Year 2019 Operating and Financial Results on February 27, 2020"
2020-02-03,Factors Setting the Tone for Bristol-Myers (BMY) Q4 Earnings
2020-01-29,"Biotech Stock Roundup: EPZM Drug Gets FDA Nod, XLRN &amp; HEPA Surge on Study Data"
2020-01-29,"The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut"
